CHAPTER 1ADMISSIBILITY
SECTION 1 Application for renewal
Article 1Submission of the application
1.
F1An application for the renewal of an approval of an active substance must be submitted by a producer of the active substance to a competent authority for a constituent territory in relation to which the active substance is approved (in this Regulation, the “assessing competent authority”) no later than three years before the expiry of the approval.
When submitting an application, the applicant may, pursuant to Article 63 of Regulation (EC) No 1107/2009, request certain information to be kept confidential. In that event, the applicant shall present such parts of the application physically separated, setting out the reasons for requesting confidentiality.
At the same time, the applicant shall submit any data protection claims pursuant to Article 59 of Regulation (EC) No 1107/2009.
F2...
F32.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3.
A joint application may be submitted by an association of producers designated by the producers for the purpose of compliance with this Regulation.
Article 2Format and contents of the application
1.
The application shall be submitted in the format set out in the Annex.
2.
The application shall list the new information the applicant intends to submit. It shall demonstrate that such information is necessary in accordance with the first subparagraph of Article 15(2) of Regulation (EC) No 1107/2009.
The application shall list separately any new studies involving vertebrate animals that the applicant intends to submit.
Article 3Checking of the application
1.
Where the application has been submitted by the date provided for in the first subparagraph of Article 1(1) and contains all the elements provided for in Article 2, the F4assessing competent authority shall, within one month of the date of receipt of the application, inform the applicant F5and the other competent authorities of the date of receipt of the application and the fact that it has been submitted by the date provided for in the first subparagraph of Article 1(1) and contains all the elements provided for in Article 2.
The F6assessing competent authority shall assess any request for confidentiality. Upon a request for access to information, the F6assessing competent authority shall decide what information is to be kept confidential.
2.
Where the application has been submitted by the date provided for in the first subparagraph of Article 1(1) but one or more elements provided for in Article 2 are missing, the F7assessing competent authority shall, within one month of the date of receipt of the application, inform the applicant which elements are missing and set a period of 14 days for the submission of those elements to the F8assessing competent authority.
Where the application contains all the elements provided for in Article 2 at the expiry of that period, the F9assessing competent authority shall, without delay, proceed in accordance with paragraph 1.
3.
Where the application has not been submitted by the date provided for in the first subparagraph of Article 1(1), or where the application still does not contain all the elements provided for in Article 2 at the expiry of the period set for the submission of the missing elements in accordance with paragraph 2, the F10assessing competent authority shall, without delay, inform the applicant F11and the other competent authorities that the application is inadmissible and of the reasons why it is inadmissible.
4.
Within 14 days from the date of receipt of the information that the application has been submitted by the date provided for in the first subparagraph of Article 1(1) and that it contains all the elements provided for in Article 2, the applicant shall submit to the F12assessing competent authority a copy of the application, including the information about those parts of the application in respect of which confidentiality has been requested and justified by the applicant pursuant to Article 63 of Regulation (EC) No 1107/2009.
At the same time, the applicant shall forward a copy of the application to the F12assessing competent authority, excluding any information in respect of which confidentiality has been requested and justified by the applicant pursuant to Article 63 of Regulation (EC) No 1107/2009.
5.
Where, by the date provided for in the first subparagraph of Article 1(1), two or more applications for the same active substance have been submitted separately F13to the same assessing competent authority and each of them contains all the elements provided for in Article 2, the F14assessing competent authority shall communicate the contact details of each applicant to the other applicant(s).
6.
The F15assessing competent authority shall publish, for each active substance, the names and the addresses of the applicants whose applications have been submitted by the date provided for in the first subparagraph of Article 1(1) and contain all the elements provided for in Article 2.
Article 4Contacts prior to submission of supplementary dossiers
The applicant may request a meeting with the F16assessing competent authority to discuss the application.
If requested, such pre-submission contacts shall take place prior to the submission of supplementary dossiers, as provided for in Article 6.
Article 5Access to the application
Upon receipt of the application, as provided for in Article 3(4), the F17assessing competent authority shall make it available to the public without delay, excluding any information in respect of which confidentiality has been requested and justified by the applicant pursuant to Article 63 of Regulation (EC) No 1107/2009, unless there is an overriding public interest in its disclosure.
SECTION 2 Supplementary dossiers
Article 6Submission of supplementary dossiers
1.
Where the F18assessing competent authority has informed the applicant in accordance with Article 3(1) that its application has been submitted by the date provided for in the first subparagraph of Article 1(1) and that it contains all the elements provided for in Article 2, the applicant shall submit the supplementary dossiers to the F19assessing competent authority.
F201A.
The assessing competent authority must notify the other competent authorities as soon as reasonably practicable after receipt of the supplementary dossiers under paragraph 1.
1B.
A competent authority which receives a notification under paragraph 1A may request in writing from the applicant a copy of supplementary dossiers, which the applicant must provide as soon as reasonably practicable.
2.
The contents of the supplementary summary dossier and the supplementary complete dossier shall comply with Article 7.
F213.
The supplementary dossiers shall be submitted no later than 33 months before the expiry of the approval. F22The requirement applies to substances approved for use within Great Britain where that approval expires on or after 13 May 2026.
4.
Where there is more than one applicant requesting renewal of the approval of the same active substance, those applicants shall take all reasonable steps to submit their dossiers jointly.
Where such dossiers are not submitted jointly by all the applicants concerned, the reasons shall be set out in the dossiers.
5.
When submitting the supplementary dossiers, the applicant may pursuant to Article 63 of Regulation (EC) No 1107/2009 request certain information, including certain parts of the dossier, to be kept confidential and shall physically separate that information.
Article 7Contents of supplementary dossiers
1.
The supplementary summary dossier shall include the following:
(a)
a copy of the application;
(b)
where the applicant is joined or replaced by one or more other applicants, the name and address of that applicant or those other applicants and, if applicable, the name of the association of producers provided for in Article 1(3);
(c)
information with respect to one or more representative uses on a F23crop grown in Great Britain of at least one plant protection product containing the active substance, demonstrating that the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 are fulfilled; where the information submitted does not F24concern a crop, a justification shall be submitted;
(d)
data and risk assessments which were not part of the approval dossier or subsequent renewal dossiers and which are necessary:
- (i)
to reflect changes in legal requirements which have occurred since the approval or last renewal of the approval of the active substance concerned;
- (ii)
to reflect changes in scientific and technical knowledge since the approval or last renewal of the approval of the active substance concerned;
- (iii)
to reflect changes to representative uses; or
- (iv)
because the application is for an amended renewal;
(e)
for each point of the data requirements for the active substance, as set out in F25legislation setting out data requirements for active substances under Regulation (EC) No 1107/2009 F26in relation to each constituent territory to which the application for renewal relates, for which new data are necessary in accordance with point (d), the summaries and results of tests and studies, the name of their owner and of the person or institute that has carried them out and the reason why each test or study is necessary;
(f)
for each point of the data requirements for the plant protection product, as set out in F27legislation setting out data requirements for plant protection products under Regulation (EC) No 1107/2009 F28in relation to each constituent territory to which the application for renewal relates, for which new data are necessary in accordance with point (d), the summaries and results of tests and studies, the name of their owner and of the person or institute that has carried out the tests and studies, for one or more plant protection products which are representative of the supported uses, and the reason why each test or study is necessary;
(g)
where relevant, documented evidence as referred to in Article 4(7) of Regulation (EC) No 1107/2009;
(h)
for each test or study involving vertebrate animals, a description of the steps taken to avoid animal testing on vertebrate animals;
(i)
F21(j)
(k)
an assessment of all information submitted;
(l)
a checklist demonstrating that the supplementary dossier provided for in paragraph 3 is complete in view of the uses applied for and indicating which data are new;
(m)
the summaries and results of scientific peer-reviewed open literature, as referred in Article 8(5) of Regulation (EC) No 1107/2009.
2.
The uses referred to in paragraph 1(c) shall, where appropriate, include the uses evaluated for the approval or subsequent renewals. At least one plant protection product referred to in paragraph 1(c) shall contain no other active substance, where such a product exists for a representative use.
3.
The supplementary complete dossier shall contain the full text of each test and study report referred to in paragraph 1(e), (f) and (m).
It shall not contain any reports of tests or studies involving the deliberate administration of the active substance or the plant protection product containing it to humans.
Article 8Admissibility of the application
1.
Where the supplementary dossiers have been submitted by the date provided for in Article 6(3) and contain all the elements provided for in Article 7, the F29assessing competent authority shall, within a period of one month, inform the applicant F30and the other competent authorities of the date of receipt of the supplementary dossiers and of the admissibility of the application.
The F31assessing competent authority shall assess any requests for confidentiality. In the event of a request for access to information, the F31assessing competent authority shall decide what information is to be kept confidential.
2.
Where the supplementary dossiers have been submitted by the date provided for in Article 6(3), but one or more elements provided for in Article 7 are missing, the F32assessing competent authority shall, within a period of one month from the date of receipt of the supplementary dossiers, inform the applicant which elements are missing and set a period of 14 days for the submission of those elements to the F33assessing competent authority.
Where at the expiry of that period the supplementary dossiers contain all the elements provided for in Article 7, the F34assessing competent authority shall, without delay, proceed in accordance with paragraph 1.
3.
F35...
F36Before the end of the period stated in paragraph 1, the applicant shall forward the supplementary summary dossiers to the F37assessing competent authority, excluding any information in respect of which confidentiality has been requested and justified by the applicant pursuant to Article 63 of Regulation (EC) No 1107/2009.
4.
The F38assessing competent authority shall make the supplementary summary dossier available to the public, without delay, excluding any information in respect of which confidentiality has been requested and justified by the applicant pursuant to Article 63 of Regulation (EC) No 1107/2009, unless there is an overriding public interest in its disclosure.
5.
At the request of F39a competent authority, the applicant shall make available the dossiers submitted for the approval and subsequent renewals of the approval, where it has access to them.
6.
Where the supplementary dossiers have not been submitted by the date referred to in Article 6(3), or where at the end of the period set for the submission of the missing elements in accordance with paragraph 2 of this Article the supplementary dossiers still do not contain all the elements provided for in Article 7, the F40assessing competent authority shall, without delay, inform the applicant F41and the other competent authorities that the application is inadmissible and of the reasons why it is inadmissible.
Article 9Replacement of the applicant
An applicant may be replaced by another producer in respect of all of its rights and obligations under this Regulation by informing the F42assessing competent authority, through a joint declaration by the applicant and the other producer. In that case, the applicant and the other producer shall, at the same time, inform the F43other competent authorities and any other applicants that have submitted an application for the same active substance of the replacement.
F44Article 10Refusal of renewal where applications are inadmissible
Where all of the applications submitted for renewal of the approval of an active substance in relation to a constituent territory are inadmissible in accordance with Article 3(3) or 8(6), the competent authority for that constituent territory must refuse to renew approval of the active substance in accordance with Article 20(1)(b) of Regulation (EC) No 1107/2009 of the European Parliament and of the Council.
CHAPTER 2ASSESSMENT
Article 11Assessment by the F45assessing competent authority
1.
Where the application is admissible in accordance with Article 8(1), the F46assessing competent authority must, at the latest F2113 months after the date referred to in Article 6(3), prepare and submit to the F47other competent authorities a report assessing whether the active substance can be expected to meet the approval criteria, as provided for in Article 4 of Regulation (EC) No 1107/2009 (‘the draft renewal assessment report’).
2.
The draft renewal assessment report shall also include the following:
(a)
a recommendation with regard to the renewal of the approval;
(b)
a recommendation on whether the substance should be considered a ‘low-risk’ substance;
(c)
a recommendation on whether the substance should be considered a candidate for substitution;
(d)
where relevant, a proposal to set maximum residue levels;
F21(e)
a suggestion for the classification, or its confirmation, where applicable, or reclassification of the active substance in accordance with the criteria of Regulation (EC) No 1272/2008, as specified in and consistent with the dossier to be submitted pursuant to paragraph 9;
(f)
a conclusion on which of the new studies included in the supplementary dossiers are relevant for the assessment;
F48(g)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F48(h)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3.
The F49assessing competent authority shall make an independent, objective and transparent assessment in the light of current scientific and technical knowledge. It shall take into account the supplementary dossiers, and, where appropriate, the dossiers submitted for the approval and subsequent renewals of approval.
4.
The F50assessing competent authority shall first establish whether the approval criteria set out in points 3.6.2, 3.6.3, 3.6.4 and 3.7 of Annex II to Regulation (EC) No 1107/2009 are satisfied.
Where those criteria are not satisfied, the draft renewal assessment report shall be limited to those parts of the assessment, unless Article 4(7) of Regulation (EC) No 1107/2009 applies.
5.
F535A.
The 13 month period provided for in paragraph 1 is extended by any additional period set in accordance with paragraph 5.
5B.
The additional period described in paragraph 5 must be for no more than 6 months and ceases at the earlier of—
(a)
the date on which the assessing competent authority receives the additional information;
(b)
the expiry of the additional period.
F546.
The assessing competent authority may, as it considers appropriate—
(a)
obtain independent scientific advice;
(b)
consult with the other competent authorities.
7.
Information submitted by the applicant without having been requested, or provided after the expiry of the period set for its submission in accordance with the first sentence of paragraph 5, shall not be taken into account, unless it is submitted in accordance with Article 56 of Regulation (EC) No 1107/2009.
8.
F55When submitting the draft renewal assessment report to the other competent authorities, the assessing competent authority must require the applicant to notify the other competent authorities of the existence of any updated supplementary summary dossiers. Article 15(4) of Regulation (EC) No 1107/2009 applies to a notification under this paragraph as it applies to a notification under Article 15(3) of that Regulation.
The applicant may pursuant to Article 63 of Regulation (EC) No 1107/2009 request such information to be kept confidential. Any such requests shall be addressed to the F56assessing competent authority.
F579.
The F58assessing competent authority shall at the latest at the time of submission of the draft renewal assessment report submit a proposal to the F59Agency pursuant to Article F6037A(2)(2) of Regulation (EC) No 1272/2008 and in accordance with the Agency’s requirements to obtain an opinion on a F61mandatory classification and labelling of the active substance at least for the following hazard classes:
explosives,
acute toxicity,
skin corrosion/irritation,
serious eye damage/eye irritation,
respiratory or skin sensitisation,
germ cell mutagenicity,
carcinogenicity,
reproductive toxicity,
specific target organ toxicity – single exposure,
specific target organ toxicity – repeated exposure;
hazardous to the aquatic environment.
The F62assessing competent authority shall duly justify its view that the criteria for classification for one or more of these hazard classes are not fulfilled.
Where a proposal for classification of an active substance has already been submitted to the Agency and its assessment is ongoing, the F62assessing competent authority shall submit an additional proposal for classification, limited to any hazard classes listed above that are not covered by the pending proposal unless new information has become available that was not part of the pending dossier as regards the hazard classes listed above.
For the hazard classes, which are already covered by an existing opinion of the Committee for Risk Assessment of the Agency set up pursuant to Article 76(1)(c) of Regulation (EC) No 1907/2006, F63or by an Agency opinion, whether or not this opinion has formed the basis of a decision concerning an entry for F64mandatory classification and labelling of a substance in F65the GB mandatory classification and labelling list, it is sufficient that the rapporteur Member State duly justifies in its submission to the Agency that the existing opinion, or where it has already formed the basis of a decision concerning the inclusion in F66the GB mandatory classification and labelling list, the existing classification remains valid as regards the hazard classes listed in the first subparagraph. The Agency may provide its views regarding the F67assessing competent authority’s submission.
F68Article 11a
F57Article 11b
Article 12Comments on the draft renewal assessment report
F211.
2.
The F75assessing competent authority shall make the draft renewal assessment report available to the public, after giving the applicant two weeks to request, pursuant to Article 63 of Regulation (EC) No 1107/2009, that certain parts of the draft renewal assessment report are kept confidential.
3.
The F76assessing competent authority shall allow a period of 60 days from the date the report is made available to the public for the submission of written comments. Such comments shall be communicated to the F76assessing competent authority, which shall collate and forward those comments, including its own comments, to the F77other competent authorities.
4.
The F78assessing competent authority shall make the updated supplementary summary dossiers available to the public, excluding any information in respect of which confidentiality has been requested and justified by the applicant pursuant to Article 63 of Regulation (EC) No 1107/2009, unless there is an overriding public interest in its disclosure.
Article 13Conclusion by the F79assessing competent authority
1.
F21Within five months from the expiry of the period referred to in Article 12(3), or within two weeks from the adoption of the opinion of the F80Agency referred to in Article F8137A(4) of Regulation (EC) No 1272/2008, if any adopted, whichever occurs later, the F82assessing competent authority shall adopt a conclusion in the light of current scientific and technical knowledge using guidance documents applicable at the date of the submission of the supplementary dossiers and in the light of the opinion of the F80Agency on whether the active substance can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009.F83The assessing competent authority may obtain independent scientific advice where it considers it appropriate to do so. The Authority shall communicate its conclusion to the applicant F84and the other competent authorities.
F85...
2.
After giving the applicant two weeks to request, pursuant to Article 63 of Regulation (EC) No 1107/2009, that certain parts of the conclusion be kept confidential, the F86assessing competent authority shall make its conclusion available to the public, excluding any information in respect of which confidentiality has been granted by the F86assessing competent authority, unless there is an overriding public interest in its disclosure.
3.
Where the F87assessing competent authority considers that additional information from the applicant is necessary, it shall F88... set a period not exceeding F8990 days for the applicant to supply such information to the F90other competent authorities and the F87assessing competent authority. The F91assessing competent authority shall, within 60 days from the date of receipt of the additional information evaluate the information received F92....
Where the first subparagraph applies, the period referred to in paragraph 1 shall be extended by the periods referred to in the first subparagraph of this paragraph.
F683a.
For the purposes of assessment of the approval criteria set out in point 3.6.5 and point 3.8.2 of Annex II to Regulation (EC) No 1107/2009 as amended by Commission Regulation (EU) 2018/605, in relation to applications submitted in accordance with Article 1 before 10 November 2018, for which the draft renewal assessment report has been submitted but the conclusion by the F93assessing competent authority is not yet adopted by that date, where the information available in the dossier is not sufficient for the F93assessing competent authority to conclude the assessment on whether these approval criteria are met, the F93assessing competent authority shall, in consultation with the F94other competent authorities, request from the applicant the additional information to be submitted to the F95assessing competent authority and the other competent authorities in the form of an updated supplementary dossier including the additional information. The F96assessing competent authority shall, in consultation with F97... the applicant, set a period for the submission of that information. Such period shall be at least of 3 months, shall not exceed 30 months, and shall be justified in relation to the type of information which has to be submitted.
Within this period set by the F98assessing competent authority, the applicant may also submit where applicable, documentary evidence showing that the conditions for the application of the derogation under Article 4(7) of Regulation (EC) No 1107/2009 are met.
Where the F99assessing competent authority is able to conclude without requesting additional information that the scientific criteria for the determination of endocrine disrupting properties set out in point 3.6.5 and/or point 3.8.2 of Annex II to Regulation (EC) No 1107/2009 are met, it shall inform the applicant. Within 3 months after being informed by the F100assessing competent authority, the applicant may submit to the F101assessing competent authority and the other competent authorities, additional information to address the approval criteria set in point 3.6.5 and/or point 3.8.2 of Annex II to Regulation (EC) No 1107/2009, and/or documentary evidence showing that the conditions for the application of the derogation under Article 4(7) of that Regulation are met.
Where the first or third subparagraphs apply, the period referred to in paragraph 1 shall be extended by the period set for submission of the additional information.
Where no additional information is submitted in accordance with the first, second or third subparagraph within the period set for its submission, the F102assessing competent authority shall, without delay, inform the applicant F103and the other competent authorities and conclude the assessment based on the available information.
Where additional information is submitted in accordance with the first, second or third subparagraph within the period set for its submission, the F104assessing competent authority shall, within 90 days from the date of receipt of the additional information evaluate the information received and F105circulate to the other competent authorities and the applicant a revised draft renewal assessment report. The F106assessing competent authority shall conduct a consultation on the revised draft renewal assessment report with F107the other competent authorities and the applicant in accordance with Article 12. The F108assessing competent authority shall adopt the conclusion referred to in paragraph 1, within 120 days from the date of F109circulation of the revised draft renewal assessment report, using the guidance for identification of endocrine disruptors applicable at the date of the submission of the updated supplementary dossier referred to in the first subparagraph.
4.
The F110assessing competent authority may F111... consult a F112... reference laboratory designated, pursuant to F113Regulation (EU) 2017/625 of the European Parliament and of the Council , for the purposes of verifying whether the analytical method for the determination of the residues proposed by the applicant is satisfactory and complies with the requirements in Article 29(1)(g) of Regulation (EC) No 1107/2009. The applicant shall, if requested by the F114... reference laboratory, provide samples and analytical standards.
F1155.
Information submitted by the applicant without having been requested, or provided after the expiry of the period set for its submission in accordance with the first subparagraph of paragraph 3 or in accordance with the first or third subparagraphs of paragraph 3a of this Article, shall not be taken into account, unless it is submitted in accordance with Article 56 of Regulation (EC) No 1107/2009.
F116Article 13a Fees and charges
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Article 14Renewal F117decision
F1181.
Article 20 of Regulation (EC) No 1107/2009 applies.
1za.
Paragraph 1a applies in relation to an application where—}
(a)
paragraph 7 of Schedule 1 to the Plant Protection Products (Miscellaneous Amendments) (EU Exit) Regulations 2019 applies in relation to that application, and
(b)
the European Food Safety Authority adopted a conclusion in relation to that application before 10th November 2018 in accordance with Article 13.
F681a.
F119...
F120For the purposes of assessment of the approval criteria set out in points 3.6.5 and 3.8.2 of Annex 2 to Regulation (EC) No 1107/2009, the assessing competent authority may decide whether additional information is required and request the applicant to submit such information to the F121assessing competent authority and the other competent authorities in the form of an updated supplementary dossier including the additional information. The F122assessing competent authority shall, in consultation with F123... the applicant, set a period for the submission of that information. Such period shall be at least of 3 months, shall not exceed 30 months, and shall be justified in relation to the type of information which has to be submitted.
Within this period set by the F124assessing competent authority, the applicant may also submit where applicable, documentary evidence showing that the conditions for the application of the derogation under Article 4(7) of Regulation (EC) No 1107/2009 are met.
Where the F125assessing competent authority is able to conclude without requesting additional information that the scientific criteria for the determination of endocrine disrupting properties set out in point 3.6.5 and/or point 3.8.2 of Annex II to Regulation (EC) No 1107/2009 are met, it shall inform the applicant. Within 3 months after being informed by the F126assessing competent authority, the applicant may submit to the F127assessing competent authority and the other competent authorities additional information to address the approval criteria set out in point 3.6.5 and/or point 3.8.2 of Annex II to Regulation (EC) No 1107/2009, and/or documentary evidence showing that the conditions for the application of the derogation under Article 4(7) of that Regulation are met.
The F128assessing competent authority shall, within 90 days from the date of receipt of the additional information evaluate the information received and F129circulate to the other competent authorities and the applicant a revised draft renewal assessment report. The F130assessing competent authority shall conduct a consultation of the revised renewal assessment report with F131the other competent authorities and the applicant in accordance with Article 12.
The F132assessing competent authority shall adopt an addendum to the conclusion referred to in paragraph 1, within 120 days from the date of F133circulation of the revised draft renewal assessment report, using the guidance for identification of endocrine disruptors applicable at the date of the submission of the updated supplementary dossier referred to in the second subparagraph.
Where no additional information is submitted in accordance with the second, the third or the fourth subparagraph within the period set for its submission, the F134assessing competent authority shall, without delay, inform the applicant F135and the other competent authorities and conclude the assessment based on the available information within 30 days from the expiry of the period referred to in the second or fourth subparagraph.
Information submitted by the applicant without having been requested, or provided after the expiry of the period set for its submission in accordance with the second or fourth subparagraph of this Article, shall not be taken into account, unless it is submitted in accordance with Article 56 of Regulation (EC) No 1107/2009.
F1362.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CHAPTER 3TRANSITIONAL AND FINAL PROVISIONS
Article 15Transitional provisions
Regulation (EU) No 1141/2010 shall continue to apply with respect to the F137existing renewal applications within the meaning of Article 1(2) of that Regulation.
F138Article 16Entry into force and application
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F139...